Hyslop Welcomes Cystic Fibrosis Drug Pricing Agreement

Hyslop Welcomes Cystic Fibrosis Drug Pricing Agreement

Local Constituency MSP for Linlithgow, Fiona Hyslop, has welcomed the Scottish Government announcement that a five year pricing agreement to supply NHS Scotland with medicines to benefit patients living with cystic fibrosis in Scotland has been secured.

The pricing agreement was made by the Scottish Government and medicines manufacturer Vertex Pharmaceuticals. It is the first agreement anywhere in the UK that allows these medicines to be available in this way.

Fiona commented:

“I know this will be welcome news to many of my constituents who suffer from or have family or friends who suffer from Cystic Fibrosis.

“This new pricing agreement will allow Cystic Fibrosis clinics to prescribe the use of medicines Orkambi® and Symkevi® to patients who believe they will benefit from their use.

“Almost half of those living with Cystic Fibrosis in Scotland may be suitable for treatment with the new medicines and I am very pleased that this pricing agreement has been reached to make it possible.”